Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GDC-229 vs Metronidazole Gel in Bacterial Vaginosis
NCT03091777Phase 3Completed
- Sponsor
- Balmoral Medical
- Start
- Mar 2017
- Primary completion
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of metronidazole in bacterial vaginosis (BV) (3 arms), sponsored by Balmoral Medical. Primary endpoint: Clinical Cure. Started Mar 2017; status: completed.
02
Drugs
metronidazole
03
Conditions
bacterial vaginosis (BV)
Beyond the preview
Go deeper on NCT03091777.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03091777.